Free Trial
NASDAQ:FNCH

Finch Therapeutics Group (FNCH) Stock Price, News & Analysis

Finch Therapeutics Group logo
$12.55 +0.05 (+0.40%)
As of 10:58 AM Eastern

About Finch Therapeutics Group Stock (NASDAQ:FNCH)

Key Stats

Today's Range
$12.55
$12.55
50-Day Range
$12.28
$13.75
52-Week Range
$1.41
$15.85
Volume
805 shs
Average Volume
2,081 shs
Market Capitalization
$20.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FNCH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter.

FNCH Stock News Headlines

FNCH Finch Therapeutics Group, Inc. - Seeking Alpha
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Arquitos Capital's Largest Holdings For Q1 2025
Arquitos Capital Management Q4 2024 Commentary
Finch Therapeutics announces Nasdaq delisting, SEC deregistration
Finch Therapeutics Group to Delist from Nasdaq
See More Headlines

FNCH Stock Analysis - Frequently Asked Questions

Finch Therapeutics Group's stock was trading at $11.30 on January 1st, 2025. Since then, FNCH stock has increased by 11.1% and is now trading at $12.55.

Finch Therapeutics Group, Inc. (NASDAQ:FNCH) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($6.30) EPS for the quarter, beating the consensus estimate of ($12.60) by $6.30. The firm had revenue of $11.34 million for the quarter.

Finch Therapeutics Group's stock reverse split on the morning of Monday, June 12th 2023.The 1-30 reverse split was announced on Monday, June 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Finch Therapeutics Group (FNCH) raised $101 million in an initial public offering (IPO) on Friday, March 19th 2021. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. BofA Securities, Jefferies and Evercore ISI acted as the underwriters for the IPO.

Shares of FNCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Finch Therapeutics Group investors own include CNS Pharmaceuticals (CNSP), Faraday Future Intelligent Electric (FFIE), Allarity Therapeutics (ALLR), Aridis Pharmaceuticals (ARDS), Meta Platforms (META), NVIDIA (NVDA) and Altamira Therapeutics (CYTO).

Company Calendar

Last Earnings
11/10/2021
Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:FNCH
CIK
1733257
Fax
N/A
Employees
190
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($8.82)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.75 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-69.14%
Return on Assets
-26.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.87
Quick Ratio
3.87

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.25 per share
Price / Book
0.88

Miscellaneous

Outstanding Shares
1,606,000
Free Float
885,000
Market Cap
$20.16 million
Optionable
No Data
Beta
1.21
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:FNCH) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners